Voices: Poll of the day: Should weight loss drugs like Mounjaro be widely available on the NHS?

Around 220,000 people with the ‘greatest need’ are expected to receive Mounjaro through the NHS over the next three years - (Alamy/PA)

A major expansion of NHS weight loss treatment begins today, as GPs across England are now able to prescribe Mounjaro – an injectable drug also known as tirzepatide – for the first time.

Once limited to specialist clinics or private prescriptions, Mounjaro will now be accessible through general practice for people with severe obesity, specifically, those with a BMI over 40 and at least four related health conditions, such as type 2 diabetes, heart disease, or sleep apnoea.